Redmile Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$42.4M Buy
2023
Q1
$32.6M Buy
2022
Q3
Sell
2022
Q2
$24.9M Buy
2019
Q3
Sell
2019
Q2
$8.32M Buy
2018
Q1
Sell
2017
Q4
$223K Buy
2016
Q3
Sell
2016
Q2
$25.1M Sell
2016
Q1
$39.4M Buy
2015
Q4
Sell
2015
Q3
$38.8M Buy
2015
Q2
$28.4M Buy
2014
Q4
Sell
2014
Q3
$12.8M Sell
2014
Q2
$29.1M Buy